Keywords: intermune, ph, iii, trial, infergen, completes, enrollment

Intermune Ph III trial of Infergen completes enrollment

Article | 18 July 2005

Print This

US group InterMune has completion patient enrollment in its Phase III clinical trial of daily Infergen (interferon alfacon-1) in combination ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in